AT2 receptor and tissue injury: Therapeutic implications topical collection on mediators, mechanisms, and pathways in tissue injury

Current Hypertension Reports

Volumn 16, Issue 2, 2014, Pages

  Namsolleck, Pawel ^a   Recarti, Chiara ^a   Foulquier, Sébastien ^a   Steckelings, Ulrike Muscha ^b   Unger, Thomas ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Angiotensin II; Aortic aneurysm; Apoptosis; AT2 receptor; Atherosclerosis; Cardioprotection; CGP42112; Fibrosis; Growth promotion inhibition; Hypertension; Inflammation; Myocardial infarction; Neuroprotection; Neuroregeneration; PD123319; Renin angiotensin system; Signaling; Spinal cord injury; Stroke; Tissue injury; Vascular protection

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 1 RECEPTOR;

APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; FIBROSIS; HEART PROTECTION; HUMAN; INFLAMMATION; NERVE CELL LESION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; TISSUE INJURY; ANIMAL; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HYPERTENSION; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84893775093     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-013-0416-6     Document Type: Article

References (92)

1. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415-72.
2. Unger T. The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens. 1999;17:1775-86.
3. Steckelings UM, Kaschina E, Unger T. The AT2 receptor-a matter of love and hate. Peptides. 2005;26:1401-9.
4. Steckelings UM, Unger T. Angiotensin II type 2 receptor agonists-where should they be applied? Expert Opin Investig Drugs. 2012;21:763-6.
5. Steckelings UM, Rompe F, Kaschina E, Namsolleck P, Grzesiak A, Funke-Kaiser H, et al. The past, present and future of angiotensin II type 2 receptor stimulation. J Renin-Angiotensin-Aldosterone Syst. 2010;11:67-73.
6. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92:10663-7.
7. Gallinat S, Yu M, Dorst A, Unger T, Herdegen T. Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Brain Res Mol Brain Res. 1998;57:111-22.
8. Altarche-Xifró W, Curato C, Kaschina E, Grzesiak A, Slavic S, Dong J, et al. Cardiac c-kit + AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells. 2009;27:2488-97.
9. Busche S, Gallinat S, Bohle RM, Reinecke A, Seebeck J, Franke F, et al. Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study. Am J Pathol. 2000;157:605-11.
10. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46-54.
11. Li J, Culman J, Hörtnagl H, Zhao Y, Gerova N, Timm M, et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 2005;19:617-9.
12. Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-55.
13. Walters PE, Gaspari TA, Widdop RE. Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension. 2005;45:960-6.
14. Fischer TA, Singh K, O'Hara DS, Kaye DM, Kelly RA. Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. Am J Physiol. 1998;275:H906-916.
15. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem. 1997;272:19022-6.
16. Lokuta AJ, Cooper C, Gaa ST, Wang HE, Rogers TB. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. J Biol Chem. 1994;269:4832-8.
17. Rompe F, Artuc M, Hallberg A, Alterman M, Ströder K, Thöne-Reineke C, et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension. 2010;55:924-31.
18. Wu L, Iwai M, Li Z, Shiuchi T, Min L-J, Cui T-X, et al. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol Endocrinol. 2004;18:666-78.
19. McCarthy CA, Vinh A, Callaway JK, Widdop RE. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke. 2009;40:1482-9.
20. Sumners C, Horiuchi M, Widdop RE, McCarthy C, Unger T, Steckelings UM. Protective arms of the renin-angiotensin-system in neurological disease. Clin Exp Pharmacol Physiol. 2013;40:580-8.
21. Pendergrass KD, Gwathmey TM, Michalek RD, Grayson JM, Chappell MC. The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun. 2009;384:149-54.
22. Dandapat A, Hu CP, Chen J, Liu Y, Khan JA, Remeo F, et al. Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque. Biochem Biophys Res Commun. 2008;366:871-7.
23. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 2010;459:923-39.
24. Li Z, Zhang G, Feil R, Han J, Du X. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3. Blood. 2006;107:965-72.
25. Dhande I, Ali Q, Hussain T. Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats. Hypertension. 2013;61:1218-26.
26. Curato C, Slavic S, Dong J, Skorska A, Altarche-Xifró W, Miteva K, et al. Identification of noncytotoxic and IL-10-producing CD8 + AT2R + T cell population in response to ischemic heart injury. J Immunol. 2010;185:6286-93.
27. Gelosa P, Pignieri A, Fändriks L, de Gasparo M, Hallberg A, Banfi C, et al. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens. 2009;27:2444-51.
28. Rehman A, Leibowitz A, Yamamoto N, Rautureau Y, Paradis P, Schiffrin EL. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension. 2012;59:291-9.
29. Valero-Esquitino V, Lucht K, Cirere-Salinas D, Stubbe T, Pascual A, Curato C, et al. Direct angiotensin type 2 receptor stimulation attenuates T-lymphocyte infiltration to the central nervous system and modulates T-cell differentiation. 17th Annual Meeting of the European Council for Cardiovascular Research (ECCR). La Colle sur Loup - Nice, France; 2013.
30. Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, et al. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation. 2008;118:2523-32.
31. Brassard P, Amiri F, Schiffrin EL. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension. 2005;46:598-606.
32. Jing T, Wang H, Srivenugopal KS, He G, Liu J, Miao L, et al. Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling. Int J Mol Med. 2009;24:103-10.
33. Lauer D, Slavic S, Sommerfeld M, Thöne-Reineke C, Sharkovska Y, Hallberg A, et al. AT2 receptor agonism regulates TIMP1/MMP9 axis in the heart preventing cardiac fibrosis and improving heart function after experimental myocardial infarction. Hypertension. 2013.
34. Kljajic ST, Widdop RE, Vinh A, Welungoda I, Bosnyak S, Jones ES, et al. Direct AT2 receptor stimulation is athero-protective and stabilizes plaque in Apolipoprotein E-deficient mice. Int J Cardiol. 2013;169:281-7.
35. Horiuchi M, Akishita M, Dzau VJ. Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res. 1998;24:307-14.
36. Savoia C, D'Agostino M, Lauri F, Volpe M. Angiotensin type 2 receptor in hypertensive cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20:125-32.
37. Namsolleck P, Boato F, Schwengel K, Paulis L, Matho KS, Geurts N, et al. AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol Dis. 2013;51:177-91.
38. Gallinat S, Busche S, Schütze S, Krönke M, Unger T. AT2 receptor stimulation induces generation of ceramides in PC12W cells. FEBS Lett. 1999;443:75-9.
39. Kacimi R, Gerdes AM. Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension. 2003;41:968-77.
40. Wang X, Phillips MI, Mehta JL. LOX-1 and angiotensin receptors, and their interplay. Cardiovasc Drugs Ther. 2011;25:401-17.
41. Tan NY, Li J-M, Stocker R, Khachigian LM. Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and FasL-Fas engagement. Circ Res. 2009;105:422-30.
42. Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, et al. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J. 1997;325(Pt 2):449-54.
43. Cui T, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Daviet L, et al. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cardiovasc Res. 2001;49:863-71.
44. Horiuchi M, Hayashida W, Akishita M, Tamura K, Daviet L, Lehtonen JY, et al. Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk. Circ Res. 1999;84:876-82.
45. Nouet S, Amzallag N, Li J-M, Louis S, Seitz I, Cui T-X, et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem. 2004;279:28989-97.
46. Wruck CJ, Funke-Kaiser H, Pufe T, Kusserow H, Menk M, Schefe JH, et al. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol. 2005;25:57-64.
47. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price Jr E, Roberts RL, et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 2003;22:6471-82.
48. Guimond M-O, Gallo-Payet N. How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations? Front Endocrinol (Lausanne). 2012;3:164.
49. Guimond M-O, Gallo-Payet N. The angiotensin II type 2 receptor in brain functions: an update. Int J Hypertens. 2012;2012:351758.
50. Stroth U, Meffert S, Gallinat S, Unger T. Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor. Brain Res Mol Brain Res. 1998;53:187-95.
51. Gallinat S, Csikos T, Meffert S, Herdegen T, Stoll M, Unger T. The angiotensin AT2 receptor down-regulates neurofilament M in PC12W cells. Neurosci Lett. 1997;227:29-32.
52. Beaudry H, Gendron L, Guimond M-O, Payet MD, Gallo-Payet N. Involvement of protein kinase C alpha (PKC alpha) in the early action of angiotensin II type 2 (AT2) effects on neurite outgrowth in NG108-15 cells: AT2-receptor inhibits PKC alpha and p21ras activity. Endocrinology. 2006;147:4263-72.
53. Gendron L, Laflamme L, Rivard N, Asselin C, Payet MD, Gallo-Payet N. Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Mol Endocrinol. 1999;13:1615-26.
54. Plouffe B, Guimond M-O, Beaudry H, Gallo-Payet N. Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108-15 cells. Endocrinology. 2006;147:4646-54.
55. Gendron L, Côté F, Payet MD, Gallo-Payet N. Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells. Neuroendocrinology. 2002;75:70-81.
56. Horiuchi M, Iwanami J, Mogi M. Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci. 2012;123:193-203.
57. Li J-M, Mogi M, Tsukuda K, Tomochika H, Iwanami J, Min L-J, et al. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol. 2007;21:499-511.
58. Foulquier S, Steckelings UM, Unger T. Impact of the AT(2) receptor agonist C21 on blood pressure and beyond. Curr Hypertens Rep. 2012;14:403-9.
59. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther. 2008;120:292-316.
60. Foulquier S, Steckelings UM, Unger T. Perspective: a tale of two receptors. Nature. 2013;493:S9.
61. Qi Y, Li H, Shenoy V, Li Q, Wong F, Zhang L, et al. Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Exp Physiol. 2012;97:89-101.
62. Jones ES, Black MJ, Widdop RE. Influence of angiotensin II subtype 2 receptor (AT(2)R) antagonist, PD123319, on cardiovascular remodelling of aged spontaneously hypertensive rats during chronic angiotensin II subtype 1 receptor (AT(1)R) blockade. Int J Hypertens. 2012;2012:543062.
63. Bruce E, Shenoy V, Francis J, Steckelings U, Unger T, Sumners C, et al. AT2 receptor agonist, compound 21, attenuates pulmonary hypertension and associated cardiac pathophysiology via the vasoprotective ACE2/Ang-(1-7)/Mas axis. High Blood Pressure Research (HBPR) 2012 Scientific Sessions. Washington, USA; 2012.
64. Bruce E, Shenoy V, Francis J, Steckelings U, Unger T, Sumners C, et al. Stimulation of angiotensin type 2 receptor as a potential therapy for pulmonary hypertension. High Blood Pressure Research (HBPR) 2012 Scientific Sessions. Washington, USA; 2012.
65. Senbonmatsu T, Ichihara S, Price Jr E, Gaffney FA, Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest. 2000;106:R25-29.
66. Funke-Kaiser H, Reinemund J, Steckelings UM, Unger T. Adapter proteins and promoter regulation of the angiotensin AT2 receptor-implications for cardiac pathophysiology. J Renin-Angiotensin-Aldosterone Syst. 2010;11:7-17.
67. Wang N, Frank GD, Ding R, Tan Z, Rachakonda A, Pandolfi PP, et al. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2. PLoS ONE. 2012;7:e35632.
68. Paulis L, Becker STR, Lucht K, Schwengel K, Slavic S, Kaschina E, et al. Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine- methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension. 2012;59:485-92.
69. Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, Bedja D, et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science. 2011;332:361-5.
70. Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation. 2005;112:1636-43.
71. Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P, Dzau VJ, Pratt RE. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation. 2005;112:3328-36.
72. Takata H, Yamada H, Kawahito H, Kishida S, Irie D, Kato T, et al. Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism. J Renin-Angiotensin-Aldosterone Syst. 2013.
73. Daugherty A, Rateri DL, Howatt DA, Charnigo R, Cassis LA. PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism. PLoS ONE. 2013;8:e61849.
74. Martino G, Pluchino S, Bonfanti L, Schwartz M. Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev. 2011;91:1281-304.
75. Lucius R, Gallinat S, Rosenstiel P, Herdegen T, Sievers J, Unger T. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med. 1998;188:661-70.
76. Iwai M, Liu H-W, Chen R, Ide A, Okamoto S, Hata R, et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation. 2004;110:843-8.
77. Schelman WR, Andres R, Ferguson P, Orr B, Kang E, Weyhenmeyer JA. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression. Brain Res Mol Brain Res. 2004;128:20-9.
78. Lee S, Brait VH, Arumugam TV, Evans MA, Kim HA, Widdop RE, et al. Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo. Exp Transl Stroke Med. 2012;4:16.
79. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391-7.
80. Steckelings UM, Larhed M, Hallberg A, Widdop RE, Jones ES, Wallinder C, et al. Non-peptide AT2-receptor agonists. Curr Opin Pharmacol. 2011;11:187-92.
81. Namsolleck P, Valero-Esquitino V, Lucht K, Unger T, Steckelings U. Inhibition of microglia activation and migration by direct AT2-receptor stimulation. 24th Scientific Meeting of the International Society of Hypertension. Sydney, Australia; 2012.
82. Thoene-Reineke C, Rumschüssel K, Schmerbach K, Krikov M, Wengenmayer C, Godes M, et al. Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PLoS ONE. 2011;6:e23646.
83. McCarthy CA, Vinh A, Broughton BRS, Sobey CG, Callaway JK, Widdop RE. Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats. Hypertension. 2012;60:1531-7.
84. Schwengel K, Thoene-Reineke C, Lucht K, Namsolleck P, Horiuchi M, Iwai M, et al. Direct AT2-receptor stimulation improves survival and neurological outcome after experimental stroke (MCAO) in mice. 34. Wissenschaftlicher Kongress "Hypertonie 2010" der Deutschen Hochdruckliga e. V. DHL® - Deutsche Hypertonie Gesellschaft. Berlin, Germany; 2010.
85. Laflamme L, Gasparo M, Gallo JM, Payet MD, Gallo-Payet N. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem. 1996;271:22729-35.
86. Meffert S, Stoll M, Steckelings UM, Bottari SP, Unger T. The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol. 1996;122:59-67.
87. Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam AK, Wu X, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem. 2004;47:5995-6008.
88. Reinecke K, Lucius R, Reinecke A, Rickert U, Herdegen T, Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J. 2003;17:2094-6.
89. Sakata A, Mogi M, Iwanami J, Tsukuda K, Min L-J, Fujita T, et al. Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function. Brain Res. 2009;1300:14-23.
90. Hilliard LM, Jones ES, Steckelings UM, Unger T, Widdop RE, Denton KM. Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension. 2012;59:409-14.
91. Balaratnasingam S, Janca A. Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders. Pharmacol Ther. 2012;134:116-24.
92. Nagahara AH, Tuszynski MH. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov. 2011;10:209-19.